Zhang, C., Hu, Y., Jiang, B., Yan, L., Ren, S., Chen, J., Zhou, Q., Li, D., Liu, W., Wu, Y., Zhong, W., Wang, M., Li, Z. (2026). Neoadjuvant lorlatinib in stage III NSCLC harboring ALK fusion: A phase 2 multicenter study (LORIN).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8002